Gastroenterology & Hepatology
A surgeon at work

Division of Gastroenterology & Hepatology

We focus on the prevention, diagnosis and treatment of gastrointestinal tract and liver diseases.

Leaders in the Field

The U-M Medical School Department of Internal Medicine Division of Gastroenterology and Hepatology has had a long history of excellence since 1947 that continues today. With 92 faculty, 23 fellows and over 150 staff, we are one of the largest gastroenterology practices in the country and a leader in the prevention, diagnosis and treatment of all diseases of the gastrointestinal system, from simple to complex, including those of the esophagus, stomach, small intestine, colon, rectum, liver, gallbladder, pancreas and biliary tract.

About

Learn more about the groundbreaking research, training and patient care in the Division of Gastroenterology & Hepatology.

Education

We offer three unique fellowship programs designed to prepare fellows for successful careers in gastroenterology and hepatology clinical care and research.

Research

In addition to being leaders in the clinic, our faculty are also leaders in their respective areas of research.

Faculty

See a list of the diverse faculty who guide our clinical, research and educational programs on the path to excellence.

Patient Care

Discover why we provide the highest quality of care and cutting-edge therapeutics at our clinical centers.

Giving

Your gift can help support patient care-related activities, nursing education and numerous research areas.

Join Our Team

The Division of Gastroenterology and Hepatology welcomes board certified candidates for faculty positions who have a commitment to outstanding patient care and endoscopic practice with an interest in teaching, academic medicine and scholarship.

Join Us
U-M Health Ranks Among Nation’s Best

University of Michigan Health was named among the nation’s best hospitals and nationally ranked in twelve specialties, including GI & GI Surgery, which was also recognized as best in Michigan.

Learn More About Our Rankings
Gastroenterology & Hepatology Internal Website

Resources and information for current GI & Hepatology faculty, staff and learners.

Gastroenterology & Hepatology Intranet
Empowering Well-Being & DEI

The Department of Internal Medicine Division of Gastroenterology and Hepatology is committed to creating and cultivating a diverse and inclusive community that provides our faculty, learners and staff with the opportunities and support they need to thrive.

Learn more about our DEI efforts
CME Courses

View a list of upcoming Continuing Medical Education (CME) opportunities available through the Department of Internal Medicine.

Stay Connected With Internal Medicine
Featured News & Stories See all news syringes three in a row with one with a shot going into it on a light teal background
Health Lab
TNF inhibitors prevent complications in kids with Crohn’s disease, recommended as first-line therapies
Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data. 
man in pink shirt close up with hand on stomach
Health Lab
Potential culprit identified in lingering Crohn’s disease symptoms
A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
Clarivate’s Highly Cited Researchers 2024
Department News
Internal Medicine Faculty Named to Clarivate’s Highly Cited Researchers List
Nine faculty members from the Department of Internal Medicine named to Clarivate’s Highly Cited Researchers 2024 List.
close up of sensor
Health Lab
Stent sensor can warn of blockages in the bile duct
Currently, medical providers monitor biliary stent blockages through blood tests, meaning the problem must be significant enough for the body to notice. A sensor within the stent could enable doctors to recognize that bacterial sludge is accumulating and intervene before the patient begins to fall ill.
27th Annual Liver Disease Wrap-Up
Department News
27th Annual Liver Disease Wrap-Up
Join us for the 27th Annual Liver Disease Wrap-Up conference taking place on Saturday, December 7, 2024
machine beige black
Health Lab
Histotripsy liver tumor trial successful, early clinical adoption recommended
The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert explains more about it in this article.